The largest database of trusted experimental protocols

Glutamate

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Germany

Glutamate is a laboratory reagent used in various biochemical applications. It serves as a basic amino acid that is involved in several metabolic pathways. Glutamate can be used in a range of analytical techniques to study cellular processes and molecular interactions.

Automatically generated - may contain errors

93 protocols using glutamate

1

Directed Differentiation of hESCs into Neural Lineage

Check if the same lab product or an alternative is used in the 5 most similar protocols
After being treated with dispase II for 5 min, the detached hESCs (1.0×106 cells) were partially dissociated into 200–300 µm cell clusters and transferred to 6 cm bacterial-culture dishes (Alpha Plus, Taiwan) for 2 days of culturing. The differentiating medium contained DMEM-F12 (Invitrogen) and 20% knockout serum replacement (KSR, Invitrogen), 1 mM non-essential amino acids (NEAAs, Invitrogen), 2 mM glutamate (Invitrogen) and 0.1 mM 2-mercaptoethanol (Invitrogen). The day of cell dissociation was set as D1. From D3 to D4, the cell suspensions were cultured in DMEM-F12 with 1% N2 supplement (Invitrogen), 1 mM NEAAs and 2 mM glutamate. Neural inducing factors were applied during this D3–D4 stage, including 10 µM SB431542 (Sigma-Aldrich, St. Louis, MO, USA), 0.5 µM BIO (Sigma-Aldrich) and 10 ng/mL recombinant human FGF-2 (rh-FGF2, R&D Systems, Minneapolis, MN, USA). From D5, the neural inducing factors were removed, and the cells were further cultured in neurobasal media (Invitrogen) with 1% N2 supplement and 10 ng/mL rh-FGF2.
+ Open protocol
+ Expand
2

Differentiation of iPSCs into Neural Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
When iPSCs reach 80% confluence, cells were treated with 1 mg/ml Dispase II (Roche) and harvested by scraping (Day 0). The detached cell clumps were dissociated into 200–300 μm clusters and transferred to non-coated Petri dishes for 48 h. The differentiation medium was DMEM/F12 (Invitrogen) supplied with 20% knockout serum replacement (KSR, Invitrogen), 1 mM, non-essential amino acids (NEAA, Invitrogen), 2 mM glutamate (Invitrogen) and 100 μM 2-mercaptoethanol (Invitrogen). On Day 2 of differentiation, the cell culture medium was replaced to DMEM/F12 supplied with 1% N2 supplement (Invitrogen), 1 mM NEAAs and 2 mM glutamate. The BiSF induction factors, including 10 ng/mL recombinant human FGF-2 (rh-FGF2, R&D Systems), 10 μM SB431542 (Sigma-Aldrich) and 0.5 μM BIO (Sigma-Aldrich), were added on Day 2 for 48 h. From Day 0, 10 μM Y27632 (Cayman Chemical) was provided until the end of BiSF treatment. On Day 4, the neural induction medium was removed, and the cells were cultured in neurobasal medium (Invitrogen) with 1% N2 supplement and 10 ng/mL rh-FGF2. After neural induction, the cells were dissociated into small clumps by Accutase and seeded on 1% Geltrex (Invitrogen)-coated cell culture dishes for neural maturation. Following differentiation, NPC purity was determined by immunocytochemistry staining with Nestin antibody (Biolegend, #839801).
+ Open protocol
+ Expand
3

Multilineage Differentiation Potential of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the multiple differentiation potential, MSCs were cultured until sub-confluency and induced to differentiate into the adipogenic or osteogenic lineages for 7 and 21 days, respectively. After that, the gene expression analysis and staining were performed. The adipogenic medium consisted of α-MEM (Life Technologies), 20% FBS (Life Technologies), 2 mM glutamate (Life Technologies), 100 Units/mL penicillin/streptomycin (Sigma-Aldrich) and 55 µM 2-ME (Life Technologies), 10 mM L-ascorbic acid phosphate (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), 10 mg/mL insulin (Sigma-Aldrich), 0.5 mM hydrocortisone (Sigma-Aldrich), 6 mM indomethacin (R&D systems), 50 mM isobutylmethylxanthin (Enzo life science, Tokyo, Japan), as reported [66 (link)]. Osteogenic medium consisted of α-MEM (Life technologies), 20% FBS (Life Technologies), 2 mM glutamate (Life technologies), 100 Units/mL penicillin/streptomycin (Sigma-Aldrich) and 55 µM 2-ME (Life technologies), 10 mM L-ascorbic acid phosphate (FUJIFILM Wako Pure Chemical Corporation), 200 mM β-glycerophosphate (Sigma-Aldrich), as reported [67 ]. Mineralization (calcium deposition) and lipid droplet formation were evaluated, respectively, by staining with alizarin red-S or oil red-O, as reported [68 (link),69 (link)].
+ Open protocol
+ Expand
4

Isolation and Expansion of Osteoarthritic Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cartilage tissues were obtained from four patients with end-stage OA after total knee arthroplasty (ages 71, 72, 64, and 82 years; all female) at the University Hospital of Basel under ethical agreement (Ethikkommission beider Basel, Ref.Nr. EK: 78/07). The cells were isolated as described previously elsewhere [58 (link)]. In brief, after cutting the tissues with a scalpel into small pieces, they were digested overnight in 0.2% collagenase II (300 U/mg, Worthington Biochemical Corp, Lakewood, NJ, USA) on an orbital shaker at 37 °C. The isolated chondrocytes were expanded for three passages to 80% confluency in basal medium (BM, Dulbecco’s modified Eagle medium, high glucose (DMEM)), 1 mM sodium pyruvate, 10 mM HEPES, 1% penicillin/streptomycin (P/S), and 0.29 mg/mL glutamate (all from Gibco), supplemented with 10% fetal bovine serum (FBS), 1 ng/mL transforming growth factor (TGF)-β1, and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from Fitzgerald, Acton, MO, USA) in a humidified incubator (37 °C, 5% CO2).
+ Open protocol
+ Expand
5

DT40 and HeLa Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (WT) and IP3R-deficient (TKO, cR1 DKO, cR2 DKO, and cR3 DKO) DT40 cells were provided by Prof. Tomohiro Kurosaki (RIKEN Research Center for Allergy and Immunology, Yokohama, Japan) and were cultured in suspension, in RPMI 1640 medium with glutamine (Gibco, Cat# 11875093) supplemented with penicillin/streptomycin, 2 mM L-glutamine, 10% FBS (all from GIBCO, Life Technology), 1% chicken serum (Gibco, Cat# 16110082) and 0.4% 2-mercaptoethanol in 5% CO2 and 95% air at 40 °C. DT40 cells stably expressing any IP3R or M3 construct were produced by David I. Yule, (University of Rochester, Rochester, NY) and were kept under the same conditions as above but in medium supplemented with 2 mg/ml G418 (Enzo Cat# ALX-380-013-G005).
Wild-type (WT) and IP3R-deficient (TKO) HeLa cells were provided by Katsuhiko Mikoshiba (RIKEN Brain Science Institute, Saitama, Japan). Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), with 4.5 g/l glucose (Gibco, Cat# 11965118) supplemented with 10% FBS, 2 mM glutamate, 100 units/ml penicillin/streptomycin (all from GIBCO, Life Technology),
+ Open protocol
+ Expand
6

Serum-Free Culture of Mouse Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse ESCs E14 were grown in culture dishes coated with 0.1% gelatin (Sigma) in Glasgow Minimum Essential Medium (GMEM, Gibco) supplemented with 15% fetal bovine serum (FBS, AusGeneX), 100 nM nonessential amino acids (Gibco), 1% sodium pyruvate (Gibco), 200 mM glutamate (Gibco), 1% penicillin-streptomycin (Gibco), 50 μM β-mercaptoethanol (Sigma), 10 ng/ml LIF (ESGRO), 1 μM PD0325901 (a MEK inhibitor, Selleckchem) and 3 μM CHIR99021 (a GSK inhibitor, Selleckchem). The medium was replaced every 2–3 days (32 (link),33 (link)). Cells are maintained at 37 °C in a 5% CO2 incubator.
+ Open protocol
+ Expand
7

Glioblastoma Cell Line Maintenance and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary GBM patient derived cell lines, T08-387 and GBM3359 (3359) were obtained from Dr. Jeremy Rich (The University of Pittsburg). The GBM30-luc cells were provided by Dr. Balveen Kaur (The University of Texas MD Anderson Cancer Center). These cell lines were authenticated by DNA profiling and passaged in nude mice. These cell lines were maintained as a suspension culture in neurobasal medium (Gibco) supplemented with EGF (20 ng/ml, R&D systems), FGF (20 ng/ml, R&D systems), sodium pyruvate (1×, Gibco), glutamate (1×, Gibco), 100 U/ml penicillin–streptomycin (Sigma) and B27 (1×) supplement (Gibco). Human GBM cell lines, U87 MG (HTB-14) and LN18, and HEK293 and HEK293T were obtained from ATCC. U87 MG and HEK293 cells were cultured in EMEM and 10% (v/v) FBS (Invitrogen). LN18 and HEK293T cells were cultured in DMEM, 100 U/ml penicillin–streptomycin (Sigma) and 10% (v/v) FBS (Invitrogen). All cell lines were maintained in a humidified chamber with 5% CO2. 3359-TP53 R248W cells were created using CRISPR protocol described previously25 (link).
+ Open protocol
+ Expand
8

Generating Sorafenib-Resistant Hepatocellular Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep3B cells (HBV+/HBsAg+ human HCC, HB-8064) were purchased from the American Type Culture Collection (Manassas, VA, USA) and HepG2215 cells (HBV+/HBsAg+ human hepatoblastoma) were kindly provided by Dr. Jun-Jen Liu (Institute of Medical Biotechnology, Taipei Medical University, Taipei, Taiwan). These cell lines were maintained in Dulbecco’s modified Eagle medium (DMEM, Gibco-BRL, Thermo Fisher Scientific, Waltham, MA, USA) with 10% fetal bovine serum, 3.7 g/L sodium bicarbonate (Sigma-Aldrich, St. Louis, MO, USA), 1% penicillin–streptomycin (PS, Gibco, Grand Island, NY, USA), and 1% glutamate (Gibco) in a humidified incubator in 5% CO2. Sorafenib-resistant cells (HepG2215_R and Hep3B_R) were generated by treating naïve cells (HepG2215 and Hep3B) with low to high concentrations of Sorafenib (Cell Signaling, Danvers, MA, USA) from low to high concentrations for continuing 3 months. And Sorafenib-resistant cells were maintained in 10 µM Sorafenib with the medium as mentioned above. The cell line protocol was the same as the published study by Yen-Hua Huang’s lab [23 (link)].
+ Open protocol
+ Expand
9

Isolation and Expansion of Osteoarthritic Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cartilage tissue was obtained from three patients suffering from end stage OA and undergoing total knee arthroplasty (ages 47, 60 and 82 years; all female) at the university hospital of Basel under ethical agreement (Ethikkommission beider Basel, Ref.Nr. EK: 78/07, 20. March 2007). The cells were isolated as described elsewhere [69 (link)]. Briefly, tissue samples were minced with a scalpel into small pieces and were digested overnight in 0.2% collagenase II (300 U/mg, Worthington Biochemical Corp, Lakewood, NJ, USA) on an orbital shaker at 37 °C. Then, the isolated chondrocytes were expanded for three passages to 80% confluency in basal medium (BM, Dulbecco’s modified Eagle medium, high glucose (DMEM)), 10 mM HEPES, 1 mM sodium pyruvate, 1% penicillin/streptomycin (P/S), 100 μg/mL streptomycin, and 0.29 mg/mL glutamate (all from Gibco, Paisley, UK), supplemented with 10% fetal bovine serum (FBS), 5 ng/mL fibroblast growth factor-2 (FGF-2) and 1 ng/mL transforming growth factor (TGF)ß1 (both from Fitzgerald, Acton, MO, USA) in a humidified incubator (37 °C, 5% CO2).
+ Open protocol
+ Expand
10

Influenza Virus Protein Expression and Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney 293T (HEK293T) cells were originally sourced from ITCC and routinely checked for mycoplasma infection. HEK293T cells were maintained in DMEM containing 10 % FBS, glutamate, pyruvate, and high glucose (Gibco). WSN pcDNA3-based protein expression plasmids and pPol-based viral template RNA expression plasmids were described previously [61 (link)-63 (link)]. The open reading frames of the H3N2-2017 and H3N2-1968 PB2, PB1, PA and NP genes were cloned into the pPPI4 expression vector using Gibson cloning. The firefly luciferase reporter plasmid under the control of the IFNB promoter [pIFΔ(−116)lucter] and the transfection control plasmids constitutively expressing Renilla luciferase (pTK-Renilla) were described previously [63 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!